Home » Expert Content » Biologics Development » SMARTag™ ADC Technology | Catalent in 90 Seconds

SMARTag™ ADC Technology | Catalent in 90 Seconds

Summary: SMARTag™ ADC technology enables biologic innovators to develop more efficacious antibody drug conjugates. This new platform leverages Catalent’s biologic drug development expertise, advanced GPEx® expression system, analytical services, clinical supply, clinical biomanufacturing and integrated services, offering a number of advantages to ADC developers.